We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LOTB:EURONEXT BRUSSELSLotus Bakeries NV Analysis

Data as of 2026-05-29 - not real-time

€11,140.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Lotus Bakeres NV is trading in a strong bullish technical environment – the price sits above the 20‑day (10,708) and 50‑day (10,231) SMAs, the RSI is at 68.6 and the MACD shows a bullish signal with a positive histogram. However, the stock is perched near its recent resistance of 11,180 and the computed upside/downside metric is slightly negative, indicating limited near‑term upside. Fundamentally the company delivers solid growth (10% revenue growth), high profitability (ROE ~21%) and a sustainable dividend (payout ~36% with 0.8% yield), yet valuation metrics are stretched – a trailing PE of 52.6, forward PE of 41.6 and a price‑to‑book of 10.5 place the share in the overvalued range. The low beta (≈0.06) and modest 30‑day volatility (~20%) suggest limited market‑wide risk, while the “Extreme Greed” sentiment index reflects strong investor optimism. In sum, the stock’s technical momentum is positive but its high valuation and proximity to resistance caution against aggressive short‑term buying, though the underlying business fundamentals remain compelling for longer horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance limiting upside
  • High valuation metrics (PE, P/B)
  • Bullish technical indicators but limited short‑term catalyst

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong earnings growth and high ROE
  • Sustainable dividend payout
  • Valuation pressure may temper price gains

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent revenue and margin expansion
  • Low beta and defensive consumer sector positioning
  • Dividend sustainability and solid cash flow generation

Key Metrics & Analysis

Financial Health

Revenue Growth10.30%
Profit Margin12.71%
P/E Ratio52.6
ROE20.87%
ROA9.92%
Debt/Equity36.33
P/B Ratio10.5
Op. Cash Flow€205.9M
Free Cash Flow€30.0M

Technical Analysis

TrendBullish
RSI68.6
Support€10,200.00
Resistance€11,180.00
MA 20€10,708.00
MA 50€10,231.40
MA 200€8,993.55
MACDBullish
VolumeStable
Fear & Greed Index93.27

Valuation

Fair Value€516.53
Target Price€11,129.30
Upside/Downside-0.10%
GradeOvervalued
TypeGrowth
Dividend Yield0.81%

Risk Assessment

Beta0.06
Volatility19.74%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.